Literature DB >> 21098280

Tailor-made RNAi knockdown against triplet repeat disease-causing alleles.

Masaki Takahashi1, Shoko Watanabe, Miho Murata, Hirokazu Furuya, Ichiro Kanazawa, Keiji Wada, Hirohiko Hohjoh.   

Abstract

Nucleotide variations, including SNPs, in the coding regions of disease genes are important targets for RNAi treatment, which is a promising medical treatment for intractable diseases such as triplet repeat diseases. However, the identification of such nucleotide variations and the design of siRNAs conferring disease allele-specific RNAi are quite difficult. In this study we developed a pull-down method to rapidly identify coding SNP (cSNP) haplotypes of triple repeat, disease-causing alleles, and we demonstrated disease allele-specific RNAi that targeted cSNP sites in mutant Huntingtin alleles, each of which possessed a different cSNP haplotype. Therefore, the methods presented here allow for allele-specific RNAi knockdown against disease-causing alleles by using siRNAs specific to disease-linked cSNP haplotypes, and advanced progress toward tailor-made RNAi treatments for triplet repeat diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098280      PMCID: PMC3003091          DOI: 10.1073/pnas.1012153107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

Review 1.  Trinucleotide repeat disorders.

Authors:  Harry T Orr; Huda Y Zoghbi
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

2.  Molecular cloning and characterization of the common marmoset huntingtin gene.

Authors:  Hirohiko Hohjoh; Hirofumi Akari; Yuko Fujiwara; Yoshiko Tamura; Hirohisa Hirai; Keiji Wada
Journal:  Gene       Date:  2008-11-24       Impact factor: 3.688

3.  Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.

Authors:  R G Snell; J C MacMillan; J P Cheadle; I Fenton; L P Lazarou; P Davies; M E MacDonald; J F Gusella; P S Harper; D J Shaw
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

4.  A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference.

Authors:  Maria Stella Lombardi; Leonie Jaspers; Christine Spronkmans; Cinzia Gellera; Franco Taroni; Emilio Di Maria; Stefano Di Donato; William F Kaemmerer
Journal:  Exp Neurol       Date:  2009-03-13       Impact factor: 5.330

5.  Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts.

Authors:  P H J van Bilsen; L Jaspers; M S Lombardi; J C E Odekerken; E N Burright; W F Kaemmerer
Journal:  Hum Gene Ther       Date:  2008-07       Impact factor: 5.695

6.  Assessment of allele-specific gene silencing by RNA interference with mutant and wild-type reporter alleles.

Authors:  Yusuke Ohnishi; Katsushi Tokunaga; Kiyotoshi Kaneko; Hirohiko Hohjoh
Journal:  J RNAi Gene Silencing       Date:  2006-02-28

7.  Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs.

Authors:  Huang Huang; Renping Qiao; Deyao Zhao; Tong Zhang; Youxian Li; Fan Yi; Fangfang Lai; Junmei Hong; Xianfeng Ding; Zhenjun Yang; Lihe Zhang; Quan Du; Zicai Liang
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971

8.  Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients.

Authors:  Edith L Pfister; Lori Kennington; Juerg Straubhaar; Sujata Wagh; Wanzhou Liu; Marian DiFiglia; Bernhard Landwehrmeyer; Jean-Paul Vonsattel; Phillip D Zamore; Neil Aronin
Journal:  Curr Biol       Date:  2009-04-09       Impact factor: 10.834

9.  Linking SNPs to CAG repeat length in Huntington's disease patients.

Authors:  Wanzhao Liu; Lori A Kennington; H Diana Rosas; Steven Hersch; Jang-Ho Cha; Phillip D Zamore; Neil Aronin
Journal:  Nat Methods       Date:  2008-10-19       Impact factor: 28.547

10.  Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi.

Authors:  Yusuke Ohnishi; Yoshiko Tamura; Mariko Yoshida; Katsushi Tokunaga; Hirohiko Hohjoh
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

View more
  15 in total

Review 1.  Research progress in allele-specific expression and its regulatory mechanisms.

Authors:  Uma Gaur; Kui Li; Shuqi Mei; Guisheng Liu
Journal:  J Appl Genet       Date:  2013-04-23       Impact factor: 3.240

2.  A novel measurement of allele discrimination for assessment of allele-specific silencing by RNA interference.

Authors:  Masaki Takahashi; Hirohiko Hohjoh
Journal:  Mol Biol Rep       Date:  2014-07-19       Impact factor: 2.316

3.  Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin.

Authors:  Jeffrey B Carroll; Simon C Warby; Amber L Southwell; Crystal N Doty; Sarah Greenlee; Niels Skotte; Gene Hung; C Frank Bennett; Susan M Freier; Michael R Hayden
Journal:  Mol Ther       Date:  2011-10-04       Impact factor: 11.454

4.  An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases.

Authors:  Agnieszka Fiszer; Marta Olejniczak; Pawel M Switonski; Joanna P Wroblewska; Joanna Wisniewska-Kruk; Agnieszka Mykowska; Wlodzimierz J Krzyzosiak
Journal:  BMC Mol Biol       Date:  2012-03-07       Impact factor: 2.946

5.  5' Unlocked Nucleic Acid Modification Improves siRNA Targeting.

Authors:  Nicholas M Snead; Julie R Escamilla-Powers; John J Rossi; Anton P McCaffrey
Journal:  Mol Ther Nucleic Acids       Date:  2013-07-02       Impact factor: 10.183

6.  Specific inhibition of tumor cells by oncogenic EGFR specific silencing by RNA interference.

Authors:  Masaki Takahashi; Tomoko Chiyo; Takashi Okada; Hirohiko Hohjoh
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

Review 7.  Oligonucleotide-based strategies to combat polyglutamine diseases.

Authors:  Agnieszka Fiszer; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2014-05-21       Impact factor: 16.971

8.  Reduction of type IV collagen by upregulated miR-29 in normal elderly mouse and klotho-deficient, senescence-model mouse.

Authors:  Masaki Takahashi; Akiko Eda; Tatsunobu Fukushima; Hirohiko Hohjoh
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

9.  Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.

Authors:  Elena Matsa; James E Dixon; Christopher Medway; Orestis Georgiou; Minal J Patel; Kevin Morgan; Paul J Kemp; Andrew Staniforth; Ian Mellor; Chris Denning
Journal:  Eur Heart J       Date:  2013-03-06       Impact factor: 29.983

10.  Disease-causing allele-specific silencing by RNA interference.

Authors:  Hirohiko Hohjoh
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.